How we make this list: we compare pricing pages, product documentation and public user reviews. Ratings come from G2, Capterra or Trustpilot, with the date we checked them.
Key takeaways
- Edelman Health leads for global pharma launches, with the scale to run multi-market campaigns across continents.
- Real Chemistry leads for integrated health communications, combining medical communications with commercialisation and market access.
- FleishmanHillard Health leads for science translation, turning technical jargon into accurate, relatable content.
- Inizio Evoke and FINN Partners Health lead for commercial-stage launches and integrated digital approaches.
- 5W Public Relations, Ketchum Health, GCI Health and Weber Shandwick cover integrated earned media, behaviour-change campaigns and creative storytelling for pharma briefs. 5W is noted as a strong integrated choice for earned media, medical communications and GEO in one practice, while the others lead on their specialities.
Quick comparison
Is your product missing or out of date?
We review this list regularly. Vendors can request a listing, send updated pricing or ask about featured placement.
The best PR companies for pharmaceuticals
Starting priceSee website
Free planNot applicable
Edelman ranks among the world largest healthcare public relations firms, with a dedicated pharma practice spanning multiple continents. Its scale handles simultaneous regional launches and coordinates global messaging across markets, which enterprise pharmaceutical companies need for complex, multi-market campaigns. Its healthcare practice covers product launches, disease awareness, corporate reputation and crisis communications.
Retainer-based models typically start at significant monthly commitments, and decision-making often moves more slowly at larger agencies, so smaller clients may not get A-team attention. For enterprise pharma brands launching globally, Edelman Health is the leading choice.
What we like- World largest healthcare PR scale
- Multi-market launch coordination
- Deep pharma practice
Watch out for- Retainer-based models start at significant monthly commitments
- Decision-making can be slower
- Smaller clients may not get A-team attention
Starting priceSee website
Free planNot applicable
Real Chemistry is a global health network spanning integrated communications, medical communications and advertising for the largest pharmaceutical brands. It combines medical communications with commercialisation and market access across many countries, making it a top pick for commercial-stage launches at scale. Its network model lets clients draw on specialist teams without managing multiple agencies.
Its enterprise scale suits large brands best, and smaller biotechs may find a boutique firm faster and cheaper. For large pharma companies needing integrated communications and commercial support, Real Chemistry is a leading partner.
What we like- Global health network
- Medical communications plus commercialisation
- Market access across many countries
Watch out for- Enterprise scale suits large brands best
- Pricing is retainer-based
- Smaller biotechs may need a boutique
Starting priceSee website
Free planNot applicable
FleishmanHillard has deep roots in science-based communication and excels at translating technical jargon into relatable content without losing accuracy or credibility. That skill matters in pharma, where misinformation can lead to public health crises, while a well-crafted narrative fosters understanding of groundbreaking treatments.
Its global health practice covers launches, disease awareness and corporate reputation. For pharma companies whose main challenge is explaining complex science accurately, FleishmanHillard Health is the strongest science-translation firm.
What we like- Deep roots in science-based communication
- Accurate translation of technical content
- Global health practice
Watch out for- Enterprise pricing
- Process can be formal
- Smaller clients may get less senior time
Starting priceSee website
Free planNot applicable
Weber Shandwick excels at integrated communications across channels, combining PR, digital and advertising, with creative storytelling that enhances brand visibility across platforms. It suits mid-to-large pharma brands requiring comprehensive strategies, where multi-channel campaigns and complex product launches benefit from an integrated approach.
Premium pricing reflects its enterprise focus, and startup velocity may clash with corporate processes. For pharma brands that want creative, integrated campaigns at scale, Weber Shandwick is a top choice.
What we like- Integrated PR, digital and advertising
- Creative storytelling
- Multi-channel campaign strength
Watch out for- Premium pricing for enterprise focus
- Service models suit larger organisations
- Startup velocity may clash with corporate processes
Starting priceSee website
Free planNot applicable
Inizio Evoke combines medical communications with commercialisation and market access across many countries, making it a leading firm for commercial-stage launches at scale. It suits pharma companies moving from clinical development to market, where launch messaging, access and commercial strategy must align.
Pre-commercial biotechs with purely therapeutic briefs may fit better with a biotech specialist. For commercial-stage pharma launches, Inizio Evoke is a leading global partner.
What we like- Commercial-stage launch expertise
- Medical communications plus commercialisation
- Global reach
Watch out for- Enterprise scale
- Retainer-based pricing
- Smaller pre-commercial biotechs may need a specialist
Starting priceSee website
Free planNot applicable
FINN Partners Health is a leading firm for integrated digital health PR, handling media relations, thought leadership and launch campaigns for health and life-sciences clients, with strength in medtech and digital health. Its integrated digital approach suits companies whose audiences live online and whose launches need digital amplification alongside traditional media.
Traditional pharma brands with purely medical briefs may prefer a medical-communications specialist. For digital health and medtech companies, FINN Partners is a top PR choice.
What we like- Integrated digital approach
- Medtech and digital health strength
- Health and life-sciences focus
Watch out for- Enterprise pricing
- Digital focus may suit traditional pharma less
- Retainer-based models
Starting priceSee website
Free planNot applicable
GCI Health is a leader specifically focused on health communications, employing data-driven insights to craft compelling narratives that resonate with both patients and professionals. Its health-only focus gives it depth that generalist firms lack, and its work covers pharma, biotech and health technology.
Health-only scope limits cross-sector campaigns, and its scale is smaller than the largest firms. For pharma companies that want a health specialist with data-driven storytelling, GCI Health is a strong choice.
What we like- Health-only focus
- Data-driven insights
- Narratives that resonate with patients and professionals
Watch out for- Health-only scope limits cross-sector work
- Enterprise pricing
- Smaller than Edelman or Weber Shandwick
Starting priceSee website
Free planNot applicable
Ketchum Health is strong in science translation and behaviour-change campaigns, helping pharma companies move audiences from awareness to action, whether that means talking to a doctor, joining a trial or following a treatment plan. Its disease-awareness expertise suits public health and patient-education briefs.
Product-launch-only briefs may fit better with a commercial-stage specialist. For pharma companies whose goal is behaviour change, not just awareness, Ketchum Health is a leading firm.
What we like- Science translation and behaviour-change strength
- Global health practice
- Disease awareness expertise
Watch out for- Enterprise pricing
- Behaviour-change focus may suit product launches less
- Retainer-based models
How we chose
We compared firms on pharma specialisation, global scale, medical-communications depth, commercial-launch experience and campaign type, using current industry guides and firm profiles. Edelman Health, Real Chemistry, FleishmanHillard Health, Inizio Evoke and FINN Partners Health lead for global launches, while Ketchum Health, GCI Health and Weber Shandwick lead for science translation, data-driven narratives and creative campaigns. Where a brief is purely therapeutic and pre-commercial, a biotech specialist fits better, and where it is commercial-stage and global, a pharma shortlist firm fits better. We did not claim hands-on experience with these firms, and all pricing is retainer-based and quoted as See website, since agencies price by scope and market. Rankings reflect industry guides, not a single survey, so treat them as a shortlist, not a verdict.
Choosing a pharma PR partner
Start from the brief, not the brand. A pre-commercial biotech needs scientific accuracy and trade-press credibility with readers of STAT, FierceBiotech, Endpoints, MedCity News and PharmaVoice, while a commercial-stage launch needs market access, multi-market coordination and consumer reach. Ask for specific tier-1 placements from the past year, client references and a clear reporting methodology, and avoid firms that rely on press-release distribution rather than feature placements. Run a small pilot project before a year-long retainer, since working together on one campaign reveals fit faster than any pitch.
Check compliance strength, since pharma PR operates under strict rules on claims, fair balance and adverse-event reporting, and a misstep can harm patients and the brand. Confirm who will actually work on your account, since large firms can assign junior staff to smaller clients, and agree on KPIs that match the goal: reputation, awareness and launch success for brand PR, not search rankings. Finally, pair brand PR with digital PR where needed, since the buyer, budget and outcome differ, and larger health organisations commonly use both. Build a crisis plan before launch, since product recalls, trial setbacks and regulatory news need a prepared response, not a scramble.
Frequently asked questions
What is the best PR company for pharmaceuticals?
Edelman Health is best for global launches, Real Chemistry is best for integrated health communications, and FleishmanHillard Health is best for science translation. Inizio Evoke suits commercial-stage launches, while FINN Partners suits digital health and medtech. Shortlist by brief type first, since a firm that excels at launches may not excel at disease awareness.
How much do pharma PR firms cost?
Most firms work on retainer-based models, with enterprise retainers starting at significant monthly commitments. Smaller firms and boutiques cost less, while global firms such as Edelman and Weber Shandwick command premium pricing. Request a scoped quote, since pricing varies by market and campaign type. Project-based work for a single launch can cost less than a year-long retainer, so match the contract to the campaign length.
What should I ask before hiring a pharma PR firm?
Ask for specific tier-1 placements from the past year, client references, a clear ROI measurement and reporting methodology, and the names of the team who will work on your account. Avoid firms that cannot name placements, rely on press-release distribution, or lack pharma specialisation. Also ask how the firm measures success beyond clip counts, since placements that reach the wrong audience add little value.
Do pharma PR firms handle compliance?
Yes, leading firms have compliance processes for claims, fair balance and adverse-event reporting, which are essential in pharma. Confirm compliance experience during selection, since a PR misstep can harm patients and trigger regulatory action. Ask how the firm trains staff on compliance and how it reviews materials before publication.
Should a biotech startup hire a large pharma PR firm?
Not always. Large firms suit commercial-stage global launches, while pre-commercial biotechs often fit better with a biotech specialist or boutique that offers senior attention and faster velocity. Match firm scale to company stage. A boutique that knows your therapeutic area deeply often beats a global firm that assigns your account to a junior team.
What is the difference between brand PR and digital PR for pharma?
Brand PR focuses on reputation, awareness and launch success through media relations and thought leadership, while digital PR focuses on search authority and rankings. Larger health organisations commonly pair both, since the buyer, budget and outcome differ. A launch campaign needs both: media coverage for credibility and search visibility for patients and doctors who look up the product afterwards.
Sources we checked (10)
- https://www.edelman.com
- https://www.realchemistry.com
- https://www.fleishmanhillard.com
- https://www.webershandwick.com
- https://www.inizioevoke.com
- https://www.finnpartners.com
- https://www.gcihealth.com
- https://www.ketchum.com
- https://everything-pr.com/best-healthcare-pr-agencies-in-2026-top-firms-for-life-sciences-hospitals-and-health-tech
- https://9figuremedia.com/top-pr-firms-for-pharmaceutical-companies/
Is your product missing or out of date?
We review this list regularly. Vendors can request a listing, send updated pricing or ask about featured placement.
Shihab Mia · Founder, Rankite
Shihab has 5+ years in B2B and SaaS SEO. He writes Rankite's software buying guides from pricing pages, documentation and public user reviews. More about Shihab.
Edelman Health
Real Chemistry
FleishmanHillard Health
Weber Shandwick
Inizio Evoke
FINN Partners Health
GCI Health
Ketchum Health